United States Gastroparesis Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

1.  Report Overview

1.1.  Report Description

1.2.  Research Methods

1.3.  Research Approaches

2.  Executive Summary

3.  Market Overview

3.1.  Introduction

3.2.  Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.4.  Challenges

3.3.  PEST-Analysis

3.4.  Porter's Diamond Model for the United States Gastroparesis Treatment Market

3.5.  IGR-Growth Matrix Analysis

3.6.  Value Chain Analysis of the United States Gastroparesis Treatment Market

3.7.  Competitive Landscape in the United States Gastroparesis Treatment Market

4.  The United States Gastroparesis Treatment Market by Type

4.1.  Diabetic

4.2.  Idiopathic

4.3.  Post-surgical

4.4.  Others

5.  The United States Gastroparesis Treatment Market by Drug Class

5.1.  Prokinetic Drugs

5.2.  Antiemetics

5.3.  Botulinum Toxin Injection

5.4.  Antidepressants

5.5.  Others

6.  The United States Gastroparesis Treatment Market by Treatment

6.1.  Jejunostomy

6.2.  Gastric Electric Stimulation

6.3.  Parenteral Nutrition

6.4.  Diabetic Gastroparesis

6.5.  Post-operative Gastroparesis

6.6.  Others

7.  The United States Gastroparesis Treatment Market by Distribution Channel

7.1.  Retail Pharmacies

7.2.  Hospital Pharmacies

7.3.  Others

8.  Company Profiles

8.1.  Company 1

8.2.  Company 2

8.3.  Company 3

8.4.  Company 4

8.5.  Company 5